Filing Details
- Accession Number:
- 0001213900-24-078697
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-13 21:56:09
- Reporting Period:
- 2024-09-12
- Accepted Time:
- 2024-09-13 21:56:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1832511 | P3 Health Partners Inc. | PIII | Services-Health Services (8000) | 852992794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1975600 | Cpf Iii-A Pt Spv, Llc | 980 North Michigan Avenue Chicago IL 60611 | No | No | Yes | No | |
| 1975601 | Cpf Iii Pt Spv, Llc | 980 North Michigan Avenue, Suite 1998 Chicago IL 60611 | No | No | Yes | No | |
| 1975658 | Chicago Pacific Founders Ugp Iii, Llc | 980 North Michigan Avenue, Suite 1998 Chicago IL 60611 | No | No | Yes | No | |
| 1975828 | Chicago Pacific Founders Gp Iii, L.p. | 980 North Michigan Avenue, Suite 1998 Chicago IL 60611 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-09-12 | 80,000 | $0.52 | 77,105,438 | No | 4 | P | Indirect | See Footnote |
| Class A Common Stock | Acquisiton | 2024-09-13 | 80,000 | $0.50 | 77,185,438 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.49 to $0.51. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
